BotomS.A. in liquidation
KRS: NIP: REGON:
Overview
Status
Active
Registry date
2004-03-19
Share capital
100,000.00 PLN
Registered address
Tadeusza Boya-Żeleńskiego 40/22, 95-100 Zgierz, Poland
Financials
Only balance sheet data (assets and liabilities) is available. The income statement (P&L) is not available in the source filing for this period.
Revenue history
Filing timeliness
Financial statements were filed on time, on average 147 days early.
- 202531/03/2026
- 202412/02/2025
- 202318/03/2024
- 202221/02/2023
- 202129/03/2022
- 202008/02/2021
Filed on timeDelayFiling deadline
Data and insights are generated automatically from financial statements – they may contain errors and are neither a credit assessment nor business advice.
Industry
- Manufacture of pulp, paper and paperboard (21.1)
- Manufacture of articles of paper and paperboard (21.2)
- Publishing activities (22.1)
Authorized Representatives
Tomasz Gabriel Cajdler – Liquidator
Supervisory board
Marek Andrzej Majchrzak – Supervisory Board Member
Bogusław Czesław Karewicz – Supervisory Board Member
Mirosław Kropiniewicz – Supervisory Board Member
Piotr Paweł Kurowski – Supervisory Board Member
Beneficial owners
No beneficial owners recorded for the company Botom.
Debt
No entries in the National Debtors Register (KRZ).
Public aid
No public aid cases recorded in the last 10 years.
Competitors
| Name | Revenue | Website | ||
|---|---|---|---|---|
| Aflofarm Farmacja Polskasp. z o.o. | $302,019,142.07 | aflofarm.pl | ||
| Anpharm Przedsiębiorstwo FarmaceutyczneS.A. | $111,469,394.21 | anpharm.pl | ||
| Przedsiębiorstwo Produkcji Farmaceutycznej Hasco - LekS.A. | $119,621,017.71 | hasco-lek.pl | ||
| ICN Polfa RzeszówS.A. | $85,044,250.03 | icnpolfa.pl | ||
| PolfarmexS.A. | $73,543,379.32 | polfarmex.pl | ||
| Celon PharmaS.A. | $52,550,739.16 | celonpharma.com | ||
| Toruńskie Zakłady Materiałów Opatrunkowych Tkalnie ZelówS.A. | $11,288,459.46 | kontakt.tkalniezelow.pl | ||
| Biomarsp. z o.o. | $909,113.28 | biomar.pl | ||
| Munar PharmaS.A. | $85,649.72 | munar.pl | ||
| Xenira Pharmaceuticalssp. z o.o. | $26,670.82 | xenirapharma.com |
FAQ
The company was registered in the Polish National Court Register (KRS) on March 19, 2004.
The headquarters is located at: Tadeusza Boya-Żeleńskiego 40, 95- 100 Zgierz.
The share capital of the company is PLN 100,000 (approx. $27,012).
The latest available financial statement covers the period from January 1, 2025 to December 31, 2025.
Last updated: 2026-04-01